New drug aims to keep Kids' stomachs healthy after ulcers and reflux

NCT ID NCT03553563

First seen Mar 23, 2026 · Last updated May 13, 2026 · Updated 8 times

Summary

This study tested a medicine called D961H in 50 Japanese children. The goal was to see if it could stop reflux esophagitis (heartburn damage) from coming back and prevent stomach or duodenal ulcers in kids who need long-term pain relievers or low-dose aspirin. Children took the medicine for up to 52 weeks, and doctors checked for symptom return and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Bunkyō City, 113-8431, Japan

  • Research Site

    Bunkyō City, 113-8519, Japan

  • Research Site

    Fuji-shi, 417-8567, Japan

  • Research Site

    Izumi-shi, 594-1101, Japan

  • Research Site

    Kagoshima, 890-8520, Japan

  • Research Site

    Kanazawa, 920-8641, Japan

  • Research Site

    Maebashi, 371-8511, Japan

  • Research Site

    Matsumoto-shi, 390-8621, Japan

  • Research Site

    Okayama, 701-1192, Japan

  • Research Site

    Sakaishi, 593-8304, Japan

  • Research Site

    Setagaya-ku, 157-8535, Japan

  • Research Site

    Shinjuku-ku, 160-0023, Japan

  • Research Site

    Takatsuki-shi, 569-8686, Japan

  • Research Site

    Yokohama, 230-8765, Japan

  • Research Site

    Yokohama, 232 8555, Japan

Conditions

Explore the condition pages connected to this study.